Evidence map›Paper›PMID 39027646›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2024

Radiosynthesis and preclinical evaluations of [

Ruhua Tian, Jinping Kong, Yingfang He, Guoqiang Xu, Tengxiang Chen, Junbin Han

Abstract read
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Anti-HER2 nanobody 5F7-based theranostics using [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ruhua TianDepartment of Physiology, School of Basic Medicine, Guizhou Medical University Guiyang 550009, Guizhou, China.
Jinping KongDepartment of Physiology, School of Basic Medicine, Guizhou Medical University Guiyang 550009, Guizhou, China.
Yingfang HeInstitute of Radiation Medicine, Fudan University No. 2094 Xietu Road, Shanghai 200032, China.
Guoqiang XuDepartment of Physiology, School of Basic Medicine, Guizhou Medical University Guiyang 550009, Guizhou, China.
Tengxiang ChenDepartment of Physiology, School of Basic Medicine, Guizhou Medical University Guiyang 550009, Guizhou, China.
Junbin HanDepartment of Physiology, School of Basic Medicine, Guizhou Medical University Guiyang 550009, Guizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HER2 overexpression is associated with various tumor types and prompted the development of targeted therapies. Previously,

Indexed as

Al18F-RESCA methodHER2 overexpressionPETpreclinical evaluationsVHH

Identifiers

PMID39027646
PMCPMC11253080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.